Impact of Hypoglossal Nerve Stimulation on Consumer Sleep Technology Metrics and Patient Symptoms
- 22 March 2024
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 134 (7) , 3406-3411
Abstract
Objectives: Obstructive sleep apnea (OSA) is usually assessed at discrete and infrequent timepoints. Wearable consumer sleep technologies (CST) may allow for more granular and longitudinal assessments of OSA therapy responses and OSA‐related symptoms.Methods: In this case series, we enrolled hypoglossal nerve stimulator (HGNS) patients who had an effective treatment response for an 8‐week study using a wearable CST. Participants started with “HGNS‐on,” were randomized to turn off HGNS therapy during either week 4 or 5 (“HGNS‐off”), followed by a return to therapy, “HGNS‐resume.” Participants completed validated symptom questionnaires assessing sleepiness, insomnia symptoms, functional status, and overall sleep health (Satisfaction, Alertness, Timing, Efficiency, and Duration, SATED) each week. CST metrics and survey scores were compared between HGNS treatment phases. Associations between CST metrics and survey scores were assessed.Results: Seven participants with a total of 304 nights of CST data showed no statistically significant changes in total sleep time (TST), wake time after sleep onset, or sleep efficiency (SE) across the study periods. During HGNS‐off, survey scores indicated significantly worsened OSA‐related symptom scores. Two participants had significantly higher heart rate variability (HRV) during HGNS‐off (by 3.3 and 6.3 ms) when compared to HGNS active therapy periods. Amongst CST metrics, SATED scores correlated with TST (r = 0.434, p < 0.0001), HRV (r = −0.486, p < 0.0001), and SE (r = 0.320, = 0.0014). In addition, FOSQ‐10 scores correlated with average HR during sleep (r = −0.489, p < 0.001).Conclusion: A 1‐week HGNS therapy withdrawal period impacted OSA‐related sleep symptoms. Sleep‐related metrics measured by a wearable CST correlated with symptom scores indicating potential value in the use of CSTs for longitudinal sleep‐tracking in OSA patients.Level of Evidence: 4 Laryngoscope, 134:3406–3411, 2024Keywords
This publication has 22 references indexed in Scilit:
- International Consensus Statement on Obstructive Sleep ApneaInternational Forum of Allergy & Rhinology, 2023
- Detection of COVID-19 using multimodal data from a wearable device: results from the first TemPredict StudyScientific Reports, 2022
- Association of Hypoglossal Nerve Stimulation With Improvements in Long-term, Patient-Reported Outcomes and Comparison With Positive Airway Pressure for Patients With Obstructive Sleep ApneaJAMA Otolaryngology–Head & Neck Surgery, 2021
- Characterizing Decisional Conflict in Patients Presenting to Sleep Surgery Clinic and an Exploration of Resource LimitationsThe Laryngoscope, 2021
- The Sleep of the Ring: Comparison of the ŌURA Sleep Tracker Against PolysomnographyBehavioral Sleep Medicine, 2017
- High cardiac vagal control is related to better subjective and objective sleep qualityBiological Psychology, 2015
- Predictors and patterns of insomnia symptoms in OSA before and after PAP therapySleep Medicine, 2014
- Upper-Airway Stimulation for Obstructive Sleep ApneaNew England Journal of Medicine, 2014
- Daily worry is related to low heart rate variability during waking and the subsequent nocturnal sleep periodInternational Journal of Psychophysiology, 2007
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSLEEP, 1991